Gerald D. van Eeckhout
Chairman at EmboMedics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jafar Golzarian | M | - |
EmboMedics, Inc.
 EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | 12 years |
| Eric Madson | M | - |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | - |
| Robert Halverson | M | - |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | 9 years |
| Reza Malek | M | - |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | - |
| Lihui Weng | M | - |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | - |
| Marc Sapoval | M | - |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Cohen | M | 66 |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | 2 years |
| Paul Korus | M | 67 |
University of North Dakota
| 6 years |
| Glenn Pomeroy | M | - |
University of North Dakota
| 7 years |
| David S. Finn | M | - |
University of North Dakota
| 4 years |
| Arlen Nordhagen | M | 67 |
University of North Dakota
| 4 years |
| Jan P. Rudolf | M | - |
University of North Dakota
| 4 years |
| Terry Stoa | M | - |
University of North Dakota
| 4 years |
| Robert A. Miller | M | - |
University of North Dakota
| 4 years |
| Joseph P. Peterson | M | - |
University of North Dakota
| 4 years |
| Greg Gunderson | M | - |
University of North Dakota
| 5 years |
| Pamela J. Moret | F | 68 |
University of North Dakota
| 4 years |
| Scott D. Rued | M | 67 |
University of North Dakota
| 4 years |
| Jody Feragen | F | 68 |
University of North Dakota
| 4 years |
| Kevin Lemke | M | 71 |
University of North Dakota
| 4 years |
| Kris E. Compton | F | - |
University of North Dakota
| 4 years |
| Linda Pancratz | F | - |
University of North Dakota
| 3 years |
| Jeffrey P. Vickers | M | 71 |
University of North Dakota
| 4 years |
| Randy Newman | M | 70 |
University of North Dakota
| 4 years |
| David Fennell | M | 70 |
University of North Dakota
| 4 years |
| Craig B. Nelson | M | - |
University of North Dakota
| 4 years |
| Nicholas L. Voller | M | 73 |
University of North Dakota
| 4 years |
| Linda Laskowski | F | - |
University of North Dakota
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 28 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gerald D. van Eeckhout
- Personal Network
